A new position paper from the American College of Allergy, Asthma & Immunology (ACAAI) addresses the safety of administering live vaccines to patients who are currently being treated with dupilumab, a biologic therapy for various allergic conditions.
from Medical Xpress - latest medical and health news stories https://ift.tt/4IvlToh
